METOPIRONE

This brand name is authorized in Croatia, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Japan, Malta, Netherlands, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug METOPIRONE contains one active pharmaceutical ingredient (API):

1	Mepyrapone UNII ZS9KD92H6V - METYRAPONE
	Read more about Mepyrapone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
METOPIRONE Capsules	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V04CD01	Metyrapone	V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CD Tests for pituitary function
Discover more medicines within V04CD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1688564
ES	Centro de información online de medicamentos de la AEMPS	79004
FI	Lääkealan turvallisuus- ja kehittämiskeskus	573647
GB	Medicines & Healthcare Products Regulatory Agency	40384
HK	Department of Health Drug Office	19150
HR	Agencija za lijekove i medicinske proizvode	HR-H-943646664
IL	מִשְׂרַד הַבְּרִיאוּת	563
JP	医薬品医療機器総合機構	7223001M1035
MT	Medicines Authority	AA565/18302, AA565/18304, AA883/00101
NL	Z-Index G-Standaard, PRK	1805
NZ	Medicines and Medical Devices Safety Authority	3031
PL	Rejestru Produktów Leczniczych	100323786
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66831001